Safety and Efficacy of Vilazodone in Major Depressive Disorder
Completed
Forest Laboratories
Phase 4
2011-12-01
The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed
dose levels of vilazodone compared to placebo in patients with major depressive disorder.
Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder
Completed
Forest Laboratories
Phase 4
2011-12-01
The purpose of this study was to further characterize the efficacy, safety, and tolerability
of a single fixed dose level of vilazodone compared to placebo in patients with major
depressive disorder.
Marijuana is the most commonly used illicit drug, yet few clinical trials have evaluated
pharmacotherapy treatments for marijuana dependence. This study will evaluate the efficacy of
vilazodone for reducing marijuana use in marijuana-dependent adults. A contingency management
intervention (CM)and motivational enhancement therapy (MET)will be incorporated to encourage
study engagement and retention, and genomic DNA will be extracted to characterize subjects
according to polymorphisms of genes potentially relevant to the activity of vilazodone. It is
hypothesized that vilazodone combined with MET and CM will reduce the percent of
marijuana-positive urine drug screen results in marijuana-dependent individuals as compared
to a placebo treatment combined with MET and CM.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.